chevron_leftBack
As of 13 June 2026, Enveric Biosciences, Inc. has a market cap of $10.25M USD, ranking #41155 globally and #5319 in the United States.
It ranks #3658 in the Healthcare sector, and #248 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$10.25MUSD
Enterprise Value
$5.73MUSD
EBITDA (TTM)
-$8.57MUSD
Net Income (TTM)
-$12.13MUSD
PB Ratio
1.3
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Joseph Tucker
open_in_new
Employees
6
Founded
1994
Website
enveric.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -3% | 43% | 174% | 48% | -28% | -68% |
News
Loading...
ENVB Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
ENVB
ISIN: US29405E5050
Shares Out.:
Shares Outstanding:
3.682M1
Shares Float:
3.608M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
5.16 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Enveric Biosciences, Inc.
Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. The company offers product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. It also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. The company is headquartered in Cambridge, Massachusetts.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: RVMD
|
$29.56B
288K%
|
-
|
|
LSE: INDV
|
$2.07B
20K%
1.54B GBP
|
-
|
|
OTCMKTS: NDOI
|
$1.8B
17K%
|
0.4
|
|
NASDAQ: DVAX
|
$1.76B
17K%
|
-
|
|
NASDAQ: AVBP
|
$1.33B
13K%
|
-
|
|
NYSE: BRBR
|
$1.02B
10K%
|
12.1
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TLV: TEVA
|
$36.75B
359K%
108.92B ILS
|
24.2
|
|
SHE: 002001
|
$15.84B
155K%
107.34B CNY
|
16.0
|
|
NSE: CIPLA
|
$11.16B
109K%
1.06T INR
|
23.4
|
|
NSE: LUPIN
|
$11.04B
108K%
1.05T INR
|
22.7
|
|
SHE: 002653
|
$9.09B
89K%
61.6B CNY
|
80.6
|
|
EPA: ABVX
|
$8.74B
85K%
7.57B EUR
|
-
|
chevron_leftBack